We found that BCL2, CASP3, CASP9 were significantly upregulated and CASP8 was significantly downregulated in the DLBCL samples compared with controls (p ≤ 0.05) (Figure 1B). This evidence concerns the gene CASP3 and diffuse large B-cell lymphoma.